Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series. [electronic resource]
Producer: 20130701Description: 457-63 p. digitalISSN:- 1778-7254
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Juvenile -- drug therapy
- Arthritis, Psoriatic -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Child
- Colitis, Ulcerative -- chemically induced
- Crohn Disease -- chemically induced
- Etanercept
- Female
- Follow-Up Studies
- France -- epidemiology
- Humans
- Immunoglobulin G -- therapeutic use
- Incidence
- Inflammatory Bowel Diseases -- chemically induced
- Infliximab
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Rheumatic Diseases -- drug therapy
- Spondylitis, Ankylosing -- drug therapy
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.